MedPath

AMBENYL COUGH SYRUP

AMBENYL COUGH SYRUP

Discontinued
DIN Number

00469122

Drug Class

Human

Market Date

Dec 31, 1979

Company
HC

parke-davis division, warner-lambert canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00469122
AIG Number0513508001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic
A
ATC Code
R05FB02 COUGH SUPPRESSANTS AND EXPECTORANTS
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

AMMONIUM CHLORIDEActive
Strength: 80 MG / 5 ML
Monograph: AMMONIUM CHLORIDE
BROMODIPHENHYDRAMINE HYDROCHLORIDEActive
Strength: 3.75 MG / 5 ML
Monograph: BROMODIPHENHYDRAMINE HYDROCHLORIDE
CODEINE PHOSPHATEActive
Strength: 10 MG / 5 ML
Monograph: CODEINE PHOSPHATE
DIPHENHYDRAMINE HYDROCHLORIDEActive
Strength: 8.75 MG / 5 ML
Monograph: DIPHENHYDRAMINE HYDROCHLORIDE
POTASSIUM GUAIACOL SULPHONATEActive
Strength: 80 MG / 5 ML
Monograph: POTASSIUM GUAIACOL SULPHONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.